Business Context and Reporting Period
CareDx, Inc. filed this Form 8-K on September 21, 2016, to report the entry into a Material Definitive Agreement regarding an underwritten public offering of its common stock.
Key Financial Metrics
This filing details a capital raise rather than operational performance metrics. Key financial terms of the transaction include:
- Shares Offered: 2,250,000 shares of Common Stock.
- Public Offering Price: $4.00 per share.
- Underwriting Price: $3.75 per share.
- Over-Allotment Option: Underwriters granted an option to purchase up to an additional 337,500 shares within 30 days of closing.
- Expected Net Proceeds: Approximately $7.8 million (excluding over-allotment), after deducting underwriting discounts, commissions, and estimated expenses.
The filing does not provide current revenue, profit, cash flow, margins, debt, or liquidity figures.
Material Changes
The primary material change is the execution of a Purchase Agreement with Piper Jaffray & Co. to raise capital. The closing of the offering is expected on or about September 26, 2016, subject to customary conditions.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The Company intends to use the net proceeds for general corporate purposes, though specific allocation details are not provided in this text. The offering is made pursuant to a registration statement on Form S-3 declared effective on December 4, 2015.
Risks and Contingencies:
- Closing Conditions: The transaction is subject to the satisfaction of customary closing conditions; there is no guarantee the offering will close on a timely basis or at all.
- Market Conditions: Forward-looking statements regarding proceeds are subject to market conditions and other risks detailed in periodic reports.
- Lock-Up Agreements: Directors and executive officers have entered into lock-up agreements prohibiting the sale of securities until December 16, 2016, without prior written consent.
Investor Verification Checklist
- Verify the actual closing date of the offering (expected September 26, 2016) and whether the over-allotment option was exercised.
- Confirm the final net proceeds received after all expenses and underwriting discounts.
- Review the Company's most recent periodic reports (10-K or 10-Q) for current liquidity, cash position, and burn rate to assess the impact of the $7.8 million raise.
- Check for any subsequent filings regarding the use of proceeds or changes in the lock-up agreement terms.